Global DNA Sequencing Market is Estimated to Reach $26 Billion by 2025, Says Accurize Market Research


­Global DNA Sequencing Market is Estimated to Reach $26 Billion by 2025, Says Accurize Market Research

Global DNA Sequencing Market report published by Accurize Market Research forecast that the global market is expected to reach $26 billion by 2025; growing at a CAGR of 18.7% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

To browse the complete report, visit at

Rising instances of cancer majorly driving the market

Increasing trends of personalized genomics and technological advancements in new generation sequencing procedures, inherited rare disorders, and pre and neo-natal disorders, and rising incidences of cancer are few factors driving the growth of the global DNA sequencing. Though, increasing difficulty of diseases and high development and research expenses are the restraints of the market growth. Still, personalized treatments and medicines, and non-invasive detection would provide lucrative opportunities to the market.

Market Segmentation

Global DNA Sequencing Market is split into product, application; technology, end user and geography. By product segment, the market is classified into consumable, service, and instrument. Application segment comprises of biomarkers and cancer, personalized medicine, reproductive health, diagnostics and forensics, among others. Technology segment comprises sequencing by ligation, single molecule real time sequencing, chain termination sequencing, sequencing by synthesis, pyrosequencing, ion semiconductor sequencing, and nanopore sequencing. End user segment is categorized into pharmaceutical companies, academic & government research institutes, biotechnology companies, and hospitals & clinics.

North America, Europe, Asia-Pacific and rest of the world (RoW) are the geographical segments of the market. North America is further bifurcated into countries namely; U.S., Canada and Mexico. Europe covers countries like Russia, U.K., Germany, France, Italy and Rest of Europe. Asia-Pacific countries include China, India, Japan, South Korea and Rest of Asia Pacific. Rest of the World (RoW) covers South America, Africa and Middle East.

"Consumables accounted for the largest market share in the product segment", says Accurize

Consumables contributed in the majority of the share in 2017, in the product segment. It is expected to continue its trend during the forecast period. Biomarkers and cancer occupied the largest market share in the application segment and is likely to continue its dominance throughout the forecast period 2017 – 2025.Aso, the sequencing by synthesis, on the basis of technology segment accounted for the major market share in 2017 and would continue to maintain the trend.

"North America dominated the global market with the highest market share over the forecast period", says Accurize

North America was the highest revenue generating region of the global DNA sequencing market share. Likewise, Asia-Pacific is likely to achieve the fastest CAGR during the forecast period, owing to rise in DNA sequencing applications, and increase in awareness about DNA sequencing.

Top players in the market

Major companies active in the market includeJohnson & Johnson, Abbott Laboratories, ZS Genetics, GE Healthcare Life Sciences, Siemens AG, Eurofins Scientific, Macrogen, Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories, Inc., and DNASTAR, Inc., among others.

Contact Us

Stephen Jones,

Head - Sales

Accurize Market Research



Tel: +91-612-2369997